Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Tommaso Gallina

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2025
A Response to the Letter to the Editor "Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?"Daniele Marinelli, Filippo Tommaso Gallina
European Journal of Cancer (Oxford, England : 1990)|October 12, 2025
Response to Letter Re: TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinomaFilippo Tommaso Gallina, Daniele Marinelli, Jonathan Spicer
The Annals of Thoracic Surgery|June 9, 2026
STAGE II NON-SMALL CELL LUNG CANCER: UPFRONT SURGERY OR NEOADJUVANT CHEMOIMMUNOTHERAPYRiccardo Tajè, Filippo Tommaso Gallina, Jonathan David Spicer
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2025
Response to "Neoadjuvant or Perioperative Chemoimmunotherapy Treatment in Patients With Resectable NSCLC: Still an Open Question" by Dafni et alDaniele Marinelli, Giuseppe Viscardi, Roberto Ferrara, et al.
Journal of Cardiac Surgery|March 30, 2021
Sternal wound dehiscence after median sternotomy: An alternative closure techniqueFilippo Tommaso Gallina, Enrico Melis, Daniele Forcella, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Robotic Lobectomy without Complete Fissure for Non-Small Cell Lung Cancer: Technical Aspects and Perioperative Outcomes of the Tunnel TechniqueFilippo Tommaso Gallina, Daniele Forcella, Enrico Melis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 22, 2021
Minimally invasive hilum-mediastinal lymph nodes dissection for non-small cell lung cancer surgery: What is the future direction?Filippo Tommaso Gallina, Enrico Melis, Daniele Forcella, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2025
Establishing survival benchmarks in the era of peri-operative immunotherapyFilippo Tommaso Gallina, Daniele Marinelli, Brendon Stiles, et al.
International Journal of Molecular Sciences|July 8, 2017
Immunological and Inflammatory Impact of Non-Intubated Lung MetastasectomyTommaso Claudio Mineo, Francesco Sellitri, Gianluca Vanni, et al.
ANZ Journal of Surgery|June 25, 2022
Primary lung adenocarcinoma of the azygos lobe invading the azygos arch treated with robotic surgeryFilippo Tommaso Gallina, Enrico Melis, Daniele Forcella, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2025
A Response to the Letter to the Editor "Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?"Daniele Marinelli, Filippo Tommaso Gallina
European Journal of Cancer (Oxford, England : 1990)|October 12, 2025
Response to Letter Re: TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinomaFilippo Tommaso Gallina, Daniele Marinelli, Jonathan Spicer
The Annals of Thoracic Surgery|June 9, 2026
STAGE II NON-SMALL CELL LUNG CANCER: UPFRONT SURGERY OR NEOADJUVANT CHEMOIMMUNOTHERAPYRiccardo Tajè, Filippo Tommaso Gallina, Jonathan David Spicer
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2025
Response to "Neoadjuvant or Perioperative Chemoimmunotherapy Treatment in Patients With Resectable NSCLC: Still an Open Question" by Dafni et alDaniele Marinelli, Giuseppe Viscardi, Roberto Ferrara, et al.
Journal of Cardiac Surgery|March 30, 2021
Sternal wound dehiscence after median sternotomy: An alternative closure techniqueFilippo Tommaso Gallina, Enrico Melis, Daniele Forcella, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Robotic Lobectomy without Complete Fissure for Non-Small Cell Lung Cancer: Technical Aspects and Perioperative Outcomes of the Tunnel TechniqueFilippo Tommaso Gallina, Daniele Forcella, Enrico Melis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 22, 2021
Minimally invasive hilum-mediastinal lymph nodes dissection for non-small cell lung cancer surgery: What is the future direction?Filippo Tommaso Gallina, Enrico Melis, Daniele Forcella, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2025
Establishing survival benchmarks in the era of peri-operative immunotherapyFilippo Tommaso Gallina, Daniele Marinelli, Brendon Stiles, et al.
International Journal of Molecular Sciences|July 8, 2017
Immunological and Inflammatory Impact of Non-Intubated Lung MetastasectomyTommaso Claudio Mineo, Francesco Sellitri, Gianluca Vanni, et al.
ANZ Journal of Surgery|June 25, 2022
Primary lung adenocarcinoma of the azygos lobe invading the azygos arch treated with robotic surgeryFilippo Tommaso Gallina, Enrico Melis, Daniele Forcella, et al.
Pageof 6